U.S. REITS Stock News

NYSE:OUT
NYSE:OUTSpecialized REITs

OUTFRONT Media Refinances Debt And Weighs Dilution Against Growth Story

OUTFRONT Media (NYSE:OUT) has launched a private offering of US$500 million of 6.000% senior notes due 2034. The company plans to use the proceeds to redeem its outstanding senior notes due 2027 ahead of schedule. OUTFRONT Media also filed a new shelf registration to issue common stock for its employee stock ownership plan. OUTFRONT Media is an outdoor advertising company, with assets such as billboards and transit displays that connect brands with commuters and urban audiences. The fresh...
NYSE:NX
NYSE:NXBuilding

Quanex Building Products (NX) Small Q2 Profit Tests Bullish Margin Recovery Narrative

Quanex Building Products (NX) opened Q2 2026 with total revenue of US$462.4 million and basic EPS of US$0.07, while the trailing twelve months show revenue of US$1.9 billion and a basic EPS loss of US$5.65 as the stock trades around US$15.42. The company has seen quarterly revenue move from US$452.5 million in Q2 2025 to US$462.4 million in Q2 2026, with basic EPS shifting from US$0.44 to US$0.07 over the same period. This sets up a picture where top line scale contrasts with pressured...
NYSE:RL
NYSE:RLLuxury

A Look At Ralph Lauren (RL) Valuation As Shares Trade Near Recent Levels And DCF Points To Undervaluation

Ralph Lauren stock snapshot after recent performance Ralph Lauren (RL) has been relatively steady in recent trading, with the stock close to its recent level of $366.55. Short term returns over the past week and month sit in low single digits. Over the past 3 months and year, total returns have been stronger, while longer multiyear figures are higher again. That backdrop gives investors context as they weigh the company’s current value score of 2. See our latest analysis for Ralph Lauren. For...
NYSE:RGA
NYSE:RGAInsurance

RGA’s US$1.5b Equitable Deal Reshapes Life Reinsurance Risk Profile

Reinsurance Group of America (NYSE:RGA) has entered into a $1.5 billion reinsurance agreement with Equitable. The deal covers $32 billion in life insurance policies, transferring a large book of risk to RGA. The transaction is expected to materially expand RGA's business footprint in life reinsurance. For investors watching NYSE:RGA, this agreement comes with the stock recently around $204.96 and multi-year returns of 50.2% over 3 years and 83.1% over 5 years. The size of the Equitable...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Assessing Alliance Resource Partners (ARLP) Valuation As Mixed Recent Returns Put The Stock Back On Investors’ Radar

Why Alliance Resource Partners Stock Is Back on Investors’ Radar Alliance Resource Partners (ARLP) has drawn attention after recent trading data showed a mixed return pattern, with the stock up over the past month but down over the past 3 months. That split performance, alongside a last close of US$25.62 and a market cap of about US$3.3b, is prompting investors to reassess how the partnership’s coal operations and royalties business fit into a broader income and value-focused portfolio. See...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Is MannKind (MNKD) Now An Opportunity After A 39% Year To Date Share Price Decline?

If you are wondering whether MannKind at around US$3.40 is a bargain or a value trap, the key question is how its current price compares with what the business might be worth. The stock has had a weak run recently, with the share price down about 9.8% over the last week, 3.4% over the past month, and 39.3% year to date, contributing to a 22.4% decline over the last year and a 16.0% fall over five years. Recent coverage has focused on MannKind's position within the broader Biotechs industry...
NYSE:APAM
NYSE:APAMCapital Markets

Will APAM’s US$186 Billion AUM Update Amid Liquidity Jitters Change Artisan Partners’ Narrative?

In early June 2026, Artisan Partners Asset Management reported preliminary assets under management of US$186.0 billion as of May 31, while broader sector rotation and concerns around redemption limits at peers stirred sentiment across alternative asset managers. This combination of firm-specific asset data and industry-wide liquidity worries has sharpened investor focus on how Artisan Partners’ business mix and expansion plans interact with market conditions. Next, we will examine how the...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Sanmina (SANM) Valuation Check After Strong Multi Period Returns And ZT Systems Acquisition Plans

Why Sanmina stock is drawing fresh attention Sanmina (SANM) is back on investor radar after a sharp single day move, with the stock falling 0.1% in the latest session but still reflecting strong longer term total returns. That combination, a modest daily decline alongside sizeable gains over the past month, past 3 months, year to date and past year, invites a closer look at what kind of company is sitting behind the recent share price action. See our latest analysis for Sanmina. Sanmina’s...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

Assessing Moog (MOG.A) Valuation After A Strong Year Of Share Price Performance

Moog stock snapshot after recent performance Moog (MOG.A) has drawn investor attention after a strong run over the past year, with the stock up about 99% on a total return basis and recent gains over the past month and past 3 months. See our latest analysis for Moog. With the share price at about $368.25, Moog has seen a 17.3% 1 month share price return and a 47.4% year to date share price return, while the 1 year total shareholder return of 99.2% and 5 year total shareholder return of 330.4%...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Mattel Expands Barbie Momentum Into Films Partnerships And Brick Shop Sets

Mattel (NasdaqGS:MAT) is extending the Barbie movie momentum with a planned Masters of the Universe film. The company is launching a Barbie themed campaign with Dunkin' that brings the brand into food and beverage. Mattel is rolling out Mattel Brick Shop building sets, entering direct competition with established building brands and new product segments. For investors watching NasdaqGS:MAT, this cluster of moves sits at the intersection of toys, entertainment, and consumer partnerships...
NYSE:EL
NYSE:ELPersonal Products

Is It Time To Reassess Estée Lauder (EL) After Sharp Multi‑Year Share Price Declines?

If you are wondering whether Estée Lauder Companies stock is starting to look interesting on price alone, the recent mix of long term losses and shorter term gains makes it a timely moment to reassess what you are really paying for. The stock last closed at US$83.49, with the share price down 6.1% over the past week and down 3.1% over the past month, even though the 1 year return sits at 23.7% after large declines of 50.0% over 3 years and 70.0% over 5 years. These moves come as investors...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital’s Fortune 500 Entry And Morgan Stanley Link Test Valuation

Galaxy Digital (NasdaqGS:GLXY) appears on the Fortune 500 list for the first time, marking a new level of scale and recognition for the crypto focused financial services company. Morgan Stanley Wealth Management and Galaxy Digital announce a partnership to support institutional crypto lending and access to regulated exchange traded products. The tie up is aimed at making it easier for institutional clients to move between direct crypto exposure and listed vehicles within existing wealth...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

A Look At Travere Therapeutics (TVTX) Valuation After New Long Term FILSPARI FSGS Data

Travere Therapeutics (TVTX) is back in focus after new long term data from its Phase 3 DUPLEX Study open label extension showed sustained, clinically meaningful proteinuria reductions in focal segmental glomerulosclerosis patients on FILSPARI. See our latest analysis for Travere Therapeutics. The latest DUPLEX data and recent licensing moves have arrived after a powerful run, with Travere’s share price up 58.07% over 90 days and a 1 year total shareholder return close to 3x, although short...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

How Broad CABOMETYX PFS Benefit At Exelixis (EXEL) Has Changed Its Investment Story

Exelixis recently reported subgroup results from the phase 3 CABINET trial showing that CABOMETYX significantly improved progression-free survival versus placebo in previously treated patients with advanced neuroendocrine tumors, regardless of functional status. Because CABOMETYX already has U.S. approval for pancreatic and extra-pancreatic neuroendocrine tumors, these ASCO 2026 data mainly strengthen the drug’s clinical profile and potential real-world uptake rather than opening an entirely...
NYSE:VG
NYSE:VGOil and Gas

Venture Global Refinancing Raises Questions On Debt Load And Future Cash Flows

Venture Global (NYSE:VG) has issued $2.25b in senior secured notes to refinance higher interest debt. The refinancing extends debt maturities and reduces borrowing costs, targeting a stronger long term balance sheet. The transaction is positioned to support the company’s future expansion plans and capital needs. For investors watching Venture Global at a share price of $12.8, this $2.25b refinancing sits alongside a mixed recent track record. The stock is up 6.3% over the past week and...
NYSE:WHD
NYSE:WHDEnergy Services

Assessing Cactus (WHD) Valuation As Growth And High P/E Meet Undervaluation Signals

Why Cactus stock is drawing fresh attention Cactus (WHD) is back on investor radars after recent trading left the stock at a last close of $56.62, with returns mixed across the past week, month, and past 3 months. See our latest analysis for Cactus. While the share price slipped around 4% in the last session and is slightly down over the week, the 30 day share price return of 4.6% and year to date share price gain of 20.4% suggest momentum has generally been building. This is supported by a 1...
NYSE:SM
NYSE:SMOil and Gas

What SM Energy (SM)'s Debt Cuts, Asset Sale and Buybacks Shift About Its Shareholder Playbook

SM Energy Company recently declared a quarterly cash dividend of US$0.22 per share, payable on June 22, 2026 to shareholders of record as of June 8, 2026, while also redeeming all remaining 6.75% senior notes due 2026 and closing a US$900 million South Texas asset sale to cut debt. These actions, alongside record 2025 operating cash flow, higher 2026 production guidance, Civitas merger synergies, a 10% dividend increase and planned share repurchases, point to a company prioritizing balance...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Is It Too Late To Consider Berkshire Hathaway (BRK.B) After Recent Valuation Signals?

Wondering if Berkshire Hathaway stock at around US$488 a share still offers value or if most of the upside is already priced in? This article walks through what the numbers are saying about valuation. The stock has moved 2.9% over the past week and 2.6% over the past month, while the year to date return is down 1.8% and the 1 year return is down 1.1%. This helps frame how the market has recently been reassessing both opportunity and risk. Recent coverage has focused on Berkshire Hathaway's...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Assessing GitLab (GTLB) Valuation After AI Pivot, Guidance Boost And Restructuring Uncertainty

GitLab (GTLB) has become a focus for investors after reporting quarterly revenue and earnings above expectations, lifting full year guidance while simultaneously announcing a large restructuring centered on AI priorities and cost savings. See our latest analysis for GitLab. Recent news around Q1 beats, higher guidance and the AI focused restructuring has come alongside a 19.8% 1 month share price return and 26.6% 3 month share price return. However, the 1 year total shareholder return is...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Is It Time To Reassess Corebridge Financial (CRBG) After Its Recent Share Price Weakness?

If you are wondering whether Corebridge Financial at around US$26.86 is priced for opportunity or already reflects expectations, the next sections will focus squarely on what the current market price might be implying. The stock has been weak in the short term, with the share price down 0.5% over the last week, down 1.6% over the past month, and down 11.6% year to date, although the three year return stands at 98.5% and the one year return is down 16.6%. Recent coverage has focused on...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is It Too Late To Consider Eli Lilly (LLY) After Strong Multi Year Share Price Gains

If you are wondering whether Eli Lilly stock still offers value at current levels, the answer depends heavily on which valuation lens you use and how you weigh future expectations against today's price. The stock recently closed at US$1,131.42, with returns of 2.4% over the past week, 19.3% over the past month, 4.7% year to date, 48.0% over the last year and 159.1% over the past three years. Recent headlines have continued to focus on Eli Lilly's role in large pharmaceutical markets and the...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare’s Fortune 1000 Rise And Leadership Shift For Future Scale

In June 2026, Alignment Healthcare (NasdaqGS:ALHC) was named to the Fortune 1000 list for the second year in a row. The company advanced more than 196 positions and is the only business solely focused on Medicare Advantage in the Healthcare: Insurance and Managed Care category. Founder and CEO John Kao is taking on the additional role of Chairman of the Board, alongside new executive appointments aimed at supporting future scale. For investors tracking Alignment Healthcare at a share price...
NYSE:CRCL
NYSE:CRCLSoftware

Circle (CRCL) Faces New Stablecoin Rivals as EURC Share Climbs and Insiders Trim Stakes

In early June 2026, reports emerged that Visa, Mastercard, Stripe, and potentially Coinbase were developing a new stablecoin platform that could compete with Circle Internet Group’s USDC, while Circle also expanded distribution through partners such as Hyperliquid and Nium and saw several pre-planned insider share sales and tax-related share withholdings. An interesting twist is that as regulatory changes have pushed euro stablecoins to consolidate, Circle’s EURC has grown to around half of...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron’s Global Smart Water Push Highlights Grid Edge Software Opportunity

Itron (NasdaqGS:ITRI) announced expanded smart water partnerships with Hunter Water in Australia and the Office d'Equipement Hydraulique de Corse in France. The projects involve broad deployments of advanced water metering and cloud-based management platforms across the two utilities. These initiatives target water conservation, operational efficiency, and reduced non revenue water loss in key international markets. Itron focuses on grid edge solutions for utilities, including smart...